Thursday, August 13, 2015 8:36:44 PM
But with expenses in the 4-5 million range each
Quarter, it dwarfs anything the company is going
To achieve in revenues for the next two years .
At 73 million OS , things could get out of hand
Quickly with equity raises... Especially at such
A low share price right now.
I give the company credit in stating on the CC
That they have other options available,
But I think that was just to appease us.
Stock might get a little bump, but this cash burn
Is going to keep it suppressed until it gets to
At least cash flow positive.
With 500 million in projected revenues,
It will take forever to get to at this rate.
Consider this stock dead money right now.
Sell on any bump we may get tomorrow.
Recent NBY News
- NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results • Business Wire • 05/09/2024 08:05:00 PM
- NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon • Business Wire • 05/07/2024 12:00:00 PM
- NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024 • Business Wire • 05/03/2024 10:50:00 AM
- NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales • Business Wire • 04/22/2024 10:57:00 AM
- NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity • Business Wire • 04/19/2024 10:00:00 PM
- NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses • Business Wire • 04/17/2024 10:59:00 AM
- NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results • Business Wire • 03/26/2024 08:05:00 PM
- NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 • Business Wire • 03/25/2024 10:38:00 PM
- NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023 • Business Wire • 03/14/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:52:33 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 04:52:28 PM
- NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales • Business Wire • 01/30/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 01:00:12 PM
- NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network • Business Wire • 01/09/2024 02:15:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 01/04/2024 04:50:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 12:58:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:32:03 PM
- NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes • Business Wire • 12/06/2023 11:50:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:10:51 PM
- NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results • Business Wire • 11/09/2023 09:05:00 PM
- NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023 • Business Wire • 11/02/2023 10:50:00 AM
- NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs • Business Wire • 10/11/2023 12:00:00 PM
- NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference • Business Wire • 10/02/2023 10:50:00 AM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft • Business Wire • 09/14/2023 12:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM